Long-Term Clinical and Radiographic Outcomes Following Freehand and Guided Dental Implant Placeme… (NCT07373548) | Clinical Trial Compass
CompletedNot Applicable
Long-Term Clinical and Radiographic Outcomes Following Freehand and Guided Dental Implant Placement: A Randomized Controlled Trial Follow-Up
Hungary96 participantsStarted 2019-02-11
Plain-language summary
This study is a long-term clinical follow-up of a previously conducted randomized trial comparing different levels of surgical guidance in dental implant placement. The follow-up phase aims to evaluate peri-implant clinical and radiographic outcomes over an extended observation period of up to 67 months. Clinical parameters and marginal bone level changes are assessed to determine whether the accuracy benefits observed at implant placement translate into favorable long-term biological outcomes.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Age between 18 and 75 years
* Partial edentulism in the maxilla or mandible involving 1-6 missing teeth, with no more than three adjacent missing teeth
* Clinical conditions suitable for implant placement as assessed by the investigator or principal investigator (adequate bone and soft tissue conditions and acceptable occlusion)
* Ability to communicate effectively with the investigators and willingness to comply with study procedures
* Provision of written informed consent
Exclusion Criteria:
* • Pregnancy or breastfeeding
* Women of childbearing potential without adequate contraception (for radiological safety reasons)
* Conditions preventing safe intraoral manipulation (e.g., limited mouth opening, pronounced gag reflex)
* Current or previous bisphosphonate therapy
* History of radiotherapy involving the maxilla or mandible
* International normalized ratio (INR) \> 2.5
* Known HIV, hepatitis B, or hepatitis C infection
* Known allergy to any component of the implant or surgical guide system
* Poor oral hygiene
* Substance abuse
* Smoking
* Untreated periodontal disease
* Any systemic disease or condition judged by the principal investigator to pose an unacceptable risk to the participant or to compromise study completion
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.